+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Caffeine Powder Market Size, Share & Trends Analysis Report By Source, By Application (Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Others), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • May 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5976291
The Europe Caffeine Powder Market would witness market growth of 4.8% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 7,690.1, showcasing a growth of 11.9% (2020-2023).

Natural caffeine is increasingly sought after in the caffeine powder market due to its perceived health benefits, clean label appeal, and sustainability credentials. Derived from natural sources such as coffee beans or tea leaves, natural caffeine offers consumers a more wholesome alternative to synthetic counterparts. Natural caffeine is often preferred by health-conscious consumers who prioritize organic and minimally processed ingredients in their dietary supplements, beverages, and other products. Additionally, natural caffeine contains phytonutrients and antioxidants inherent to its source, which some believe may offer additional health benefits beyond caffeine's stimulant properties. Thus, the Germany market consumed 509.47 tonnes of naturally sourced caffeine powder in 2023.



The Germany market dominated the Europe Caffeine Powder Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $105.3 Million by 2031. The UK market is exhibiting a CAGR of 3.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 5.5% during (2024 - 2031).

Nootropic supplements, also known as cognitive enhancers or smart drugs, contain this powder and other compounds believed to improve cognitive function, memory, and mental clarity. Caffeine enhances alertness, concentration, and focus by blocking adenosine receptors in the brain, leading to increased neurotransmitter activity. Nootropic formulations containing this powder are popular among students, professionals, and individuals seeking improved cognitive performance.

The adoption of this powder has steadily increased in recent years, driven by several factors influencing consumer behavior and market dynamics. For example, with the proliferation of information about health, wellness, and nutrition, consumers are becoming more aware of the effects and benefits of caffeine consumption. As a result, many individuals actively seek out this powder as a convenient and effective way to incorporate caffeine into their daily routines. Increased awareness of caffeine’s stimulant properties and potential benefits for energy, focus, and cognitive function has fueled interest in this powder products.

Pharmaceutical companies often use caffeine in medications for its stimulant properties. As the pharmaceutical industry grows in Belgium, there may be a heightened demand for this powder as an ingredient in pharmaceutical formulations. According to the International Trade Administration (ITA), Belgium’s industry spends $1.64 billion (€1.5 billion) on R&D annually, equivalent to 40 percent of all private investment made in Belgium. The growth of the pharmaceutical sector in Belgium could foster research and innovation in caffeine-based pharmaceuticals. Similarly, with the rise of the cosmetics industry in Poland, there might be a growing demand for beauty supplements that contain caffeine. As per the quarterly report by the Polish Investment and Trade Agency focused on the cosmetics sector, the Polish cosmetics industry achieved a significant value close to €4 billion in 2020. Positioned as the fifth-largest cosmetics industry within the European Union, the cosmetics sector’s exports contributed to approximately 1.6% of the total goods exported by Poland in 2021. Thus, the growing cosmetics industry and rising pharmaceutical sector in the region propel the market’s growth.

Based on Source, the market is segmented into Synthetic Caffeine, and Natural Caffeine. Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Cosmetics & Personal Care, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • BASF SE
  • CSPC Pharmaceutical Group Limited
  • Shandong Xinhua Pharmaceuticals Co., Ltd.
  • Aarti Pharmalabs Limited
  • Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
  • Alpspure Lifesciences Pvt. Ltd.
  • Merck KGaA
  • Archer Daniels Midland Company
  • Cargill, Incorporated
  • Wacker Chemie AG

Market Report Segmentation

By Source (Volume, Tonnes, USD Billion, 2020-31)
  • Synthetic Caffeine
  • Natural Caffeine
By Application (Volume, Tonnes, USD Billion, 2020-31)
  • Pharmaceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Others
By Country (Volume, Tonnes, USD Billion, 2020-31)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Caffeine Powder Market, by Source
1.4.2 Europe Caffeine Powder Market, by Application
1.4.3 Europe Caffeine Powder Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Caffeine Powder Market by Source
4.1 Europe Synthetic Caffeine Market by Country
4.2 Europe Natural Caffeine Market by Country
Chapter 5. Europe Caffeine Powder Market by Application
5.1 Europe Pharmaceuticals Market by Country
5.2 Europe Food & Beverages Market by Country
5.3 Europe Cosmetics & Personal Care Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Caffeine Powder Market by Country
6.1 Germany Caffeine Powder Market
6.1.1 Germany Caffeine Powder Market by Source
6.1.2 Germany Caffeine Powder Market by Application
6.2 UK Caffeine Powder Market
6.2.1 UK Caffeine Powder Market by Source
6.2.2 UK Caffeine Powder Market by Application
6.3 France Caffeine Powder Market
6.3.1 France Caffeine Powder Market by Source
6.3.2 France Caffeine Powder Market by Application
6.4 Russia Caffeine Powder Market
6.4.1 Russia Caffeine Powder Market by Source
6.4.2 Russia Caffeine Powder Market by Application
6.5 Spain Caffeine Powder Market
6.5.1 Spain Caffeine Powder Market by Source
6.5.2 Spain Caffeine Powder Market by Application
6.6 Italy Caffeine Powder Market
6.6.1 Italy Caffeine Powder Market by Source
6.6.2 Italy Caffeine Powder Market by Application
6.7 Rest of Europe Caffeine Powder Market
6.7.1 Rest of Europe Caffeine Powder Market by Source
6.7.2 Rest of Europe Caffeine Powder Market by Application
Chapter 7. Company Profiles
7.1 BASF SE
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 CSPC Pharmaceutical Group Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Shandong Xinhua Pharmaceutical Co. Ltd
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Aarti Pharmalabs Limited
7.4.1 Company Overview
7.4.2 Financial Analysis, etc.
7.4.3 Research & Development Expenses
7.4.4 SWOT Analysis
7.5 Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Alpspure Lifesciences Pvt. Ltd.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Merck KGaA
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Archer Daniels Midland Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Cargill, Incorporated
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Wacker Chemie AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis

Companies Mentioned

  • BASF SE
  • CSPC Pharmaceutical Group Limited
  • Shandong Xinhua Pharmaceuticals Co., Ltd.
  • Aarti Pharmalabs Limited
  • Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
  • Alpspure Lifesciences Pvt. Ltd.
  • Merck KGaA
  • Archer Daniels Midland Company
  • Cargill, Incorporated
  • Wacker Chemie AG

Methodology

Loading
LOADING...